Reference number : 236-2012-2013-Q2-00513, amendment number : , agreement type : G, recipient legal name : MATEEN, Farrah J, recipient country : US, recipient province : nan, recipient city : Baltimore, recipient postal code : nan, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 250000.0, agreement start date : 2012-07-01, agreement end date : 2013-12-31, description english : Telomere Length as a Putative Biomarker of Human Immunodeficiency Virus-Associated Cognitive Impairment, description french : Telomere Length as a Putative Biomarker of Human Immunodeficiency Virus-Associated Cognitive Impairment, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2012-13 to 2017-18)

Start date may be subject to change.  Funding for awards must commence within 12 months of the date of offer.

The grant or award is funded as part of the Canadian Strategy on HIV/AIDS in collaboration with the Public Health Agency of Canada, additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2012-13 à 2017-18)

La date de début peut être sujet au changement.  Le financement des bourses doit commencer dans les 12 mois suivant la date à laquelle elles ont été offertes.

La subvention ou bourse est financée dans le cadre de la stratégie canadienne sur le VIH/sida en collaboration avec l'agence de la santé publique du Canada., owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada